Observational Study of Denosumab (Prolia®) in Postmenopausal Women With Osteoporosis

Impact of Vertebral Fracture Knowledge on Persistence in Subjects Taking Glucocorticoid Therapy

NCT00616694 ·Status: COMPLETED ·Phase: PHASE4

Denosumab Safety Assessment in Multiple Observational Databases

NCT02520362 ·Status: COMPLETED

Phase 2a Study on Intravenous Infusion of Autologous Osteoblastic Cells in Severe Osteoporosis

NCT02061995 ·Status: COMPLETED ·Phase: PHASE2

Study Investigating PK, PD, Efficacy, Safety, and Immunogenicity of Biosimilar Denosumab (GP2411) in Patients With Postmenopausal Osteoporosis

NCT03974100 ·Status: COMPLETED ·Phase: PHASE3

A Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosis

NCT04757376 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis

NCT00089791 ·Status: COMPLETED ·Phase: PHASE3

Study of Post Menopausal Osteoporosis (PMO) Among Gynecology Outpatients in Pakistan

NCT02422069 ·Status: COMPLETED

Denosumab for Prevention of Osteoporosis in Renal Transplant Recipients

NCT01377467 ·Status: COMPLETED ·Phase: PHASE3

A Study in Indian Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab

NCT01495000 ·Status: COMPLETED ·Phase: PHASE3

A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis in Mainland China

NCT06588153 ·Status: RECRUITING ·Phase: PHASE4

Denosumab for Prevention of Post-Teriparatide Bone Loss in Premenopausal Women With IOP

NCT02049866 ·Status: COMPLETED ·Phase: PHASE2

A Phase 3 Study to Compare Biosimilar Denosumab With Prolia®

NCT05405725 ·Status: COMPLETED ·Phase: PHASE3

Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis

NCT01631214 ·Status: COMPLETED ·Phase: PHASE3

Comparative Efficacy, Safety, PK, and Immunogenicity Study

NCT05853354 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of HLX14 vs. Denosumab Prolia® in Postmenopausal Women With Osteoporosis at High Risk of Fracture

NCT05352516 ·Status: COMPLETED ·Phase: PHASE3

A Study to Compare Efficacy, PK, PD, Safety and IMM of MB09 to Prolia® [EU-sourced] in Postmenopausal Osteoporosis.

NCT05338086 ·Status: COMPLETED ·Phase: PHASE3

A Study on Efficacy, Safety and Immunogenicity of 9MW0311 in Postmenopausal Women With Osteoporosis

NCT06804590 ·Status: RECRUITING ·Phase: PHASE3

Denosumab Biosimilar Injection in Post Menopausal Women With Osteoporosis

NCT05419427 ·Status: RECRUITING ·Phase: PHASE3

Continuation of Anti-osteoporotic Treatment 1 Year After Initial Administration

NCT06024148 ·Status: UNKNOWN

A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab

NCT00887965 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Actonel® After Denosumab Discontinuation in Postmenopausal Osteoporosis Women

NCT05630768 ·Status: COMPLETED ·Phase: PHASE4

Denosumab in Enhancement of Bone Bonding of Hip Prosthesis in Postmenopausal Women

NCT01926158 ·Status: COMPLETED ·Phase: PHASE4

The Optimal Long Term Treatment Strategy of Anti-resorptive Medications

NCT05091086 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis

NCT01575834 ·Status: COMPLETED ·Phase: PHASE3

A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis

NCT04729621 ·Status: COMPLETED ·Phase: PHASE3